Related Experiment Videos

[Some hemorheological factors in patients with cerebrovascular ischemia]

C E Scherle-Matamoros1, A Nasiff-Hadad, J Pérez-Nellar

  • 1Servicio de Neurología, Hospital Clínico Quirúrgico Hermanos Ameijeiras, La Habana, Cuba. csm@infomed.sld.cu

Revista De Neurologia
|March 14, 2000
PubMed

Insights

Patients with ischemic cerebrovascular disease exhibit elevated blood viscosity and plasma fibrinogen. These hemorheological factors are key indicators in understanding stroke pathology beyond embolic causes.

Area of Science:

  • Neurology
  • Hematology
  • Vascular Medicine

Context:

  • Ischemic cerebrovascular disease (ICVD) poses a significant health burden.
  • Understanding non-embolic causes of ICVD is crucial for targeted therapies.
  • Hemorheological factors play a role in microcirculation and macrocirculation disruptions.

Purpose:

  • To investigate hemorheological differences in patients with non-embolic ischemic cerebrovascular disease compared to controls.
  • To explore specific hemorheological alterations in different subtypes of ICVD (large vessel disease vs. lacunar infarcts).

Summary:

  • Forty ICVD patients and forty controls were studied.
  • Blood viscosity and plasma fibrinogen were significantly higher in ICVD patients.
  • Hematocrit levels were comparable across all groups, and no significant differences in viscosity or fibrinogen were observed between large vessel disease and lacunar infarct groups.

Impact:

  • Highlights elevated blood viscosity and fibrinogen as potential biomarkers for non-embolic ICVD.
  • Suggests that hemorheological profiles may not differentiate between major vascular alterations and lacunar infarcts.
  • Provides insights into the pathophysiological mechanisms of ischemic stroke.
Abstract

Related Concept Videos